Prostate-specific Membrane Antigen (PSMA)-specific Monoclonal Antibodies in the Treatment of Prostate and Other Cancers

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.18, Iss.4, 1999-12, pp. : 483-490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The clinical role of prostate-specific membrane antigen (PSMA)

By Chang S.S. Heston W.D.W.

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 1, 2002-01 ,pp. : 7-12

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen

By Stenman U-H. Leinonen J. Zhang W-M. Finne P.

Seminars in Cancer Biology, Vol. 9, Iss. 2, 1999-04 ,pp. : 83-93

Academic Press

Access to resources Recommend Favorite

Expression of Prostate-Specific Membrane Antigen in Normal, Benign, and Malignant Prostate Tissues

By Wright G.L. Haley C. Beckett M.L. Schellhammer P.F.

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 1, 1995-01 ,pp. : 18-28

Elsevier

Access to resources Recommend Favorite

Kinetics of Prostate-specific Antigen After Manipulation of the Prostate

By Bossens M.M.F. Van Straalen J.P. De Reijke T.M. Kurth K.H. Sanders G.T.B.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 682-685

Elsevier

Access to resources Recommend Favorite

The contribution of dendritic cells to immune responses against urological cancers - T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

By Troy A. Davidson P. Atkinson C. Hart D.

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 1, 1998-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite